Market Cap

Biomerica, Inc. Market Capitalization:

$7.5 Million

USD as of Jan. 1, 2026

business Biomerica, Inc. Company Profile

Biomerica, Inc. Main Stock Listing

NASDAQ: BMRA

Market Capitalization History of Biomerica, Inc.

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Top Competitors by Market Capitalization

Industry: Diagnostics & Research
Company Market Cap (USD)
Thermo Fisher Scientific $222.61 B
Danaher $164.98 B
Siemens Healthineers AG $57.84 B
IDEXX Laboratories, Inc. $53.62 B
Lonza Group Ltd $47.58 B
Sector: Healthcare
Company Market Cap (USD)
Lilly $968.50 B
Johnson & Johnson $499.57 B
AbbVie $405.28 B
Roche $332.12 B
UnitedHealth Group $304.72 B

Yearly evolution of Biomerica, Inc. market cap

Date Market Cap YoY Change
Jan. 1, 2026 $7.5 M -32.32%
Jan. 1, 2025 $11.0 M -37.61%
Jan. 1, 2024 $17.7 M -56.32%
Jan. 1, 2023 $40.4 M -31.92%
Jan. 1, 2022 $59.4 M -37.35%
Jan. 1, 2021 $94.8 M 122.95%
Jan. 1, 2020 $42.5 M 20.55%
Jan. 1, 2019 $35.3 M -39.62%
Jan. 1, 2018 $58.4 M 51.26%
Jan. 1, 2017 $38.6 M 140.87%
Jan. 1, 2016 $16.0 M 23.66%
Jan. 1, 2015 $13.0 M 3.33%
Jan. 1, 2014 $12.5 M -25.00%
Jan. 1, 2013 $16.7 M 110.53%
Jan. 1, 2012 $7.9 M 50.00%
Jan. 1, 2011 $5.3 M 0.00%
Jan. 1, 2010 $5.3 M -26.92%
Jan. 1, 2009 $7.3 M -62.86%
Jan. 1, 2008 $19.5 M 129.51%
Jan. 1, 2007 $8.5 M 27.08%
Jan. 1, 2006 $6.7 M 17.07%
Jan. 1, 2005 $5.7 M -18.00%
Jan. 1, 2004 $7.0 M 138.10%
Jan. 1, 2003 $2.9 M -62.50%
Jan. 1, 2002 $7.8 M -31.08%
Jan. 1, 2001 $11.3 M

Market capitalization is calculated from the opening stock price at the beginning of each year.

Biomerica, Inc. Categories

United States languages Healthcare languages Diagnostics & Research
United States Healthcare United States Diagnostics & Research

Stocks & Indices

Biomerica, Inc. has the following listings and related stock indices.


Stock: NASDAQ: BMRA

What is a company's market capitalization?

The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.